The starting point is our workshop curriculum, a customizable resource to introduce the 10-part advocacy strategy development process. It helps new and experienced advocates assess policy advocacy options, plan goals and activities, and develop a comprehensive strategy for advocacy impact.

The curriculum includes the following resources (available in English and French) which enable advocates and facilitators to build the capacity of their own and other organizations:

• Facilitator’s guide
• Facilitator’s slide set
• Training of facilitators manual
• Workbook for advocates

To increase the number of advocates who are able to access our capacity strengthening tools, PATH has adapted its workshop curriculum on advocacy strategy development to an online platform. The interactive e-course also allows users the flexibility to pace their learning and fosters a customized learning experience through the support provided in discussion forums.

To access the course, you will need to create an account. From the login screen, select “new account” and follow the steps to create an account and utilize the course.

If you have any difficulty accessing the course please email advocacyandpolicy@path.org.

One of the most effective tools in advocacy is building and strengthening coalitions representing diverse perspectives. PATH has established several coalitions, strengthened the ability—collectively and individually—of members to advance their policy advocacy goals, and in some cases transitioned management to a local partner or an independent operating structure. To document and help others replicate these successful efforts, we have augmented our curricula to include a facilitator’s guide (available in English and French) and a facilitator’s slide set with a specialized module on strengthening advocacy coalitions.

Oxygen therapy is an essential part of ending preventable deaths among newborns, children, and adults globally.

This primer provides the data, messages, and resources to help understand the planning, policies, and technologies involved in oxygen delivery scale-up. The materials are useful to anyone who wants to learn about scaling up access to oxygen and integrating oxygen delivery across national and subnational policies, programs, and health budgets.

This brief provides an overview of program-based budgeting and associated performance frameworks and advice on choosing oxygen-related indicators to include in program-based budgets.

This guide describes how the Global Financing Facility (GFF) investment case process can be leveraged to increase access to medical oxygen and presents practical approaches and actions that civil society and government can use throughout the GFF process to include medical oxygen.

Oxygen delivery toolkit provides a series of use cases of how countries used the tools to help advocates, implementers, and decision-makers plan, manage, and communicate the value of scaling up oxygen systems and access to pulse oximetry.

Medical oxygen needs tracker is an interactive tool to help advocates, decision-makers, and implementers communicate the importance of investing in access to medical oxygen as a critical component of health systems in low- and middle-income countries.

Subcutaneous DMPA (DMPA-SC) is an innovative and easy-to-use injectable that is transforming contraceptive access, use, and choice for women and adolescent girls. Advocates have an important role to play in making sure their country’s policies and funding support access to a broad method mix, including new options like DMPA-SC. The following resources were developed by PATH as part of the Injectables Access Collaborative, which is designed to accelerate advocacy efforts. The resources are both in English and French.

The advocacy pack for subcutaneous DMPA consists of evidence-based materials for advocates to use both for their own strategy development and for direct advocacy with decision-makers.

This policy analysis provides a high-level summary of the current state of self-injection policy development, implementation, and monitoring in 11 focus countries: Benin, DRC, Ghana, Kenya, Madagascar, Malawi, Mozambique, Nigeria, Togo, Uganda, and Zambia.

Even the most experienced advocates and policymakers need the opportunities to talk about the tools and approaches that are most successful in lasting policy change, implementation, and impact. That’s why PATH developed an innovative “learning lab” model to convene stakeholders from multiple countries on emerging topics of high importance to the field of advocacy. These interactive sessions bring together thought leaders from different disciplines to share learning and experience that give rise to “aha moments” and creative approaches or partnerships to solve challenges.

Past learning lab events:

Learning lab on accountability

Learning lab on decentralization

Prepared by the staff of the African Union Development Agency (AUDA-NEPAD) and PATH, with technical support from the Medicines Policy and Regulatory Reforms Technical committee and other external contributions. This document is meant to be used as a training guide on regulatory systems strengthening in Africa for National Medicines Regulatory Authorities, Regional Economic Communities and all other stakeholders directly or indirectly working in, or able to influence and support regulatory systems at country, regional or continental level.

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools have achieved licensure that could help change that. This toolkit includes a stand-alone RSV primer presentation and fact sheet providing an overview of RSV disease and prevention options. Also available are modular PowerPoint slides that can be mixed and matched with the primer presentation to dive deeper into key topics for informing understanding and decision-making around RSV prevention. All slides come with speaker notes.

We have also compiled a spreadsheet that provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention.

This knowledge hub is both for policymakers and implementers. We share national and subnational health and nutrition policies, strategies, plans, and guidelines that integrate ECD. These are living examples of how relevant content from the Nurturing Care Framework for ECD can be integrated into existing normative documents when dedicated technical assistance is available.

This interactive dashboard catalogues information about government and private entity commitments worldwide to improving the end-to-end research and development (R&D) ecosystem in Africa. The tool aims to increase transparency into commitments on manufacturing, clinical trials, and regulatory harmonization, including updates on progress toward meeting the commitments and their impact.

Policies for strong primary health care (PHC) systems are essential to advancing health equity, but they are complex and difficult to design. PATH created the PHC policy tracker as a consolidated source of information to equip policymakers and advocates with information about existing policies that shape PHC systems. The dashboard is designed to provide policymakers, advocates, and donors with data to shape policy dialogues—helping not only to identify strengths and weaknesses of PHC policies in your own country and around the world, but also to learn from others grappling with similar complex policy challenges.

PATH’s MNCHN Asset Tracker project provides information on the status of scale-up of key tools and interventions that improve maternal and child health and nutrition outcomes and save lives. The Asset Tracker dashboards allow users to quickly and efficiently compare different indicators across or within countries.

The COVID-19 EHS Policy Tracker project, which PATH undertook at the height of the COVID-19 pandemic in 2020, aimed to collect, catalogue, visualize, and disseminate government policy responses and other relevant information related to maintaining and adapting essential health services during COVID-19. Even as the acute stage of the pandemic has passed, this tracker remains useful for understanding how countries adapted during the pandemic.